245 related articles for article (PubMed ID: 34684141)
21. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao KT; Tyner JW; Gotlib J
Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
[TBL] [Abstract][Full Text] [Related]
22. How I treat atypical chronic myeloid leukemia.
Gotlib J
Blood; 2017 Feb; 129(7):838-845. PubMed ID: 27899359
[TBL] [Abstract][Full Text] [Related]
23. Atypical CML: diagnosis and treatment.
Breccia M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
[TBL] [Abstract][Full Text] [Related]
24. [Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia].
Gritsaev SV; Kostroma II; Zapreev IM; Shmidt AV; Tiranova SA; Balashova VA; Martynkevich IS; Chubukina ZV; Semenova NY; Chechetkin AV
Ter Arkh; 2016; 88(7):104-108. PubMed ID: 27459623
[TBL] [Abstract][Full Text] [Related]
25. An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.
Talati C; Padron E
Curr Hematol Malig Rep; 2016 Dec; 11(6):425-433. PubMed ID: 27664113
[TBL] [Abstract][Full Text] [Related]
26. Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review.
Belkhair J; Raissi A; Elyahyaoui H; Ameur MA; Chakour M
Leuk Res Rep; 2019; 12():100172. PubMed ID: 31194134
[TBL] [Abstract][Full Text] [Related]
27. ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia.
Shuai W; Zuo Z; Li N; Garces S; Jelloul FZ; Ok CY; Li S; Xu J; You MJ; Wang W; Rehder C; Jabbour EJ; Patel KP; Medeiros LJ; Yin CC
Cancer; 2023 Mar; 129(6):878-889. PubMed ID: 36583229
[TBL] [Abstract][Full Text] [Related]
28. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
29. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
30. Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms.
Hochman MJ; Savani BN; Jain T
EJHaem; 2021 Aug; 2(3):607-615. PubMed ID: 35844680
[TBL] [Abstract][Full Text] [Related]
31. Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms.
Gerke MB; Christodoulou I; Karantanos T
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568631
[TBL] [Abstract][Full Text] [Related]
32. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
Freedman JL; Desai AV; Bailey LC; Aplenc R; Burnworth B; Zehentner BK; Teachey DT; Wertheim G
Pediatr Blood Cancer; 2016 Jan; 63(1):156-9. PubMed ID: 26274939
[TBL] [Abstract][Full Text] [Related]
33. Myelodysplastic/myeloproliferative neoplasm with neutrophilia (atypical chronic myeloid leukemia-aCML).
Martino G; Quintini M; Martelli MP; Ascani S; Lazzi S; Mecucci C
Am J Hematol; 2023 Jul; 98(7):1163-1164. PubMed ID: 36594191
[TBL] [Abstract][Full Text] [Related]
34. Accelerated Phase of Atypical Chronic Myeloid Leukemia with Severe Disseminated Intravascular Coagulation at Initial Presentation.
Fujita M; Kamachi K; Yokoo M; Kidoguchi K; Kusaba K; Kizuka-Sano H; Yamaguchi K; Nishioka A; Yoshimura M; Kubota Y; Ando T; Kojima K; Kimura S
Intern Med; 2020 Jun; 59(12):1549-1553. PubMed ID: 32188810
[TBL] [Abstract][Full Text] [Related]
35. [BCR-ABL1 negative chronic myeloid leukemia: report of two cases].
Figueroa-Faúndez F; Vidal-Rojas C; Briones-Muñoz V; Chandía-Cabas M
Rev Med Chil; 2022 Mar; 150(3):397-401. PubMed ID: 36156725
[TBL] [Abstract][Full Text] [Related]
36.
Iaquinta G; Scalzulli E; Angeloni S; Carmosino I; Costa A; Ielo C; Passucci M; Masucci C; Martelli M; Grammatico P; Breccia M
Leuk Lymphoma; 2023 Oct; 64(10):1730-1732. PubMed ID: 37435984
[TBL] [Abstract][Full Text] [Related]
37. Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions.
Muramatsu H; Makishima H; Maciejewski JP
Semin Oncol; 2012 Feb; 39(1):67-73. PubMed ID: 22289493
[TBL] [Abstract][Full Text] [Related]
38. Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review.
Fontana D; Elli EM; Pagni F; Piazza R
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370785
[TBL] [Abstract][Full Text] [Related]
39. Solving the Puzzle: The Diagnosis of Atypical Chronic Myeloid Leukemia, BCR-ABL1-Negative (aCML).
Danyal K; Devitt K; Gardner JA
J Assoc Genet Technol; 2021; 47(3):127-131. PubMed ID: 34491231
[TBL] [Abstract][Full Text] [Related]
40. Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis.
Wan Z; Han B
Front Oncol; 2020; 10():579221. PubMed ID: 33117717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
